Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Company profile: QuantuMDx group limited.

Pharmacogenomics - 1 Jul 2013

Burn Jamie

Abstract excerpt

QuantuMDx Group Ltd (QMDx) is a group of companies based in the International Centre for Life, Newcastle upon Tyne, UK. The Group owns the founding patent and the exclusive worldwide license for, among others, the use of nanowires and nanotubes in DNA detection. It has further developed a patent estate around the functionalization of nanowires for DNA detection, and is working with commercial partners globally to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA
Share to Genetic Testing
Share to Oligonucleotide Array Sequence Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 23837475
DOI: 10.2217/pgs.13.72

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Company profile: QuantuMDx group limited.PMID 23837475Read ↗

A DNA Nanoflower‐Assisted Separation‐Free Nucleic Acid Detection Platform with a Commercial Pregnancy Test StripSemantic proximity Read ↗

Paper microfluidics for nucleic acid amplification testing (NAAT) of infectious diseasesSemantic proximity Read ↗

COVID-19 diagnostics: Molecular biology to nanomaterialsSemantic proximity Read ↗

Solid-State Nanopore Sizing for cfDNA Sample Quality Control in Point-of-Need SequencingSemantic proximity Read ↗

Complete sequence verification of plasmid DNA using the Oxford Nanopore Technologies’ MinION deviceSemantic proximity Read ↗

Mutation detection of urinary cell-free DNA via catch-and-release isolation on nanowires for liquid biopsy.Semantic proximity Read ↗

Shrinking DNA diagnostics to fill the markets of the future.Semantic proximity Read ↗

Ultra-fast sample-to-sequencing workflow for clinical diagnostics using micropillarsSemantic proximity Read ↗

Promise and perils of paper-based point-of-care nucleic acid detection for endemic and pandemic pathogensSemantic proximity Read ↗

Nucleic Acids Analytical Methods for Viral Infection Diagnosis: State-of-the-Art and Future PerspectivesSemantic proximity Read ↗

Visual “Dam-Break Drainage” Nucleic Acid Chips: Family-Affordable Platform for Rapid and Ultrasensitive Pathogens DetectionSemantic proximity Read ↗

Genetic analysis with pyrosequencing using loop pipetting and a light dependent resistor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.